General Information of DTT (ID: TTF8P9I)

DTT Name Diacylglycerol acyltransferase 1 (DGAT1) DTT Info
Gene Name DGAT1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [1]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
LCQ908 DMFLJHQ Familial chylomicronemia syndrome 5C80 Phase 3 [2]
AZD7687 DMS9I6A Diabetic complication 5A2Y Phase 1 [3]
P-7435 DMNZQU5 Diabetic complication 5A2Y Phase 1 [4]
------------------------------------------------------------------------------------
21 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
amidepsines DM1FUOY N. A. N. A. Patented [5]
Azole derivative 6 DMTMJ7S N. A. N. A. Patented [5]
Azole derivative 7 DMVUJGI N. A. N. A. Patented [5]
Benzamide derivative 19 DM5YNTM N. A. N. A. Patented [5]
Carbamide derivative 3 DM4ISCQ N. A. N. A. Patented [5]
Lactam derivative 1 DMDYKPC N. A. N. A. Patented [5]
Lactam derivative 2 DMT58QE N. A. N. A. Patented [5]
Lactam derivative 3 DMD0XIL N. A. N. A. Patented [5]
Lactam derivative 4 DMJ3ZAI N. A. N. A. Patented [5]
Lactam derivative 5 DMX5FYZ N. A. N. A. Patented [5]
PMID25470667-Compound-AZD3988 DM6EN54 N. A. N. A. Patented [5]
PMID25470667-Compound-BAY744113 DMY3140 N. A. N. A. Patented [5]
PMID25470667-Compound-Figure4-1A DMMVQW8 N. A. N. A. Patented [5]
PMID25470667-Compound-PF-04620110 DM0OBAW N. A. N. A. Patented [5]
Pyrazine carboxamide derivative 1 DM3RAU4 N. A. N. A. Patented [5]
Pyrazolo[1,5-a]pyrimidine derivative 28 DMG1RNL N. A. N. A. Patented [5]
Pyrazolo[1,5-a]pyrimidine derivative 29 DMCT6QW N. A. N. A. Patented [5]
Pyridine-amide derivative 1 DM9KOYX N. A. N. A. Patented [5]
Pyridine-carboximide derivative 1 DM25M8D N. A. N. A. Patented [5]
Pyridine-carboximide derivative 2 DMHXWZB N. A. N. A. Patented [5]
T863 DMX41ZF Discovery agent N.A. Patented [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 21 Patented Agent(s)
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
DS-7250 DMQK53O Diabetic complication 5A2Y Discontinued in Phase 1 [6]
JTT-553 DMI7Z1Y Obesity 5B81 Discontinued in Phase 1 [7]
PF-04620110 DMSNOH3 Type-2 diabetes 5A11 Terminated [8]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med. 2004 Mar;70(3):258-60.
2 DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Curr Opin Drug Discov Devel. 2010 Jul;13(4):489-96.
3 Clinical pipeline report, company report or official report of AstraZeneca (2011).
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033014)
5 Acyltransferase inhibitors: a patent review (2010-present).Expert Opin Ther Pat. 2015 Feb;25(2):145-58.
6 Clinical pipeline report, company report or official report of Daiichi Sankyo.
7 JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice. J Pharmacol Sci. 2015 Sep;129(1):51-8.
8 Clinical pipeline report, company report or official report of Pfizer (2011).